The first drug shown to slow Alzheimer’s disease hit the US market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage. Doctors also expect some patients will hesitate to take Leqembi due to its limited…
The first drug shown to slow Alzheimer’s hit the U.S. market over a year ago, but sales have lagged and diagnosis and treatment remain complicated. Major hospital systems have taken
Millions of older adults likely have minor memory issues that can later become dementia. But only a fraction of them are diagnosed early enough for new treatments to stand a chance.
Blood tests needed for widespread Alzheimer s diagnosis on the way – The Frontier Post thefrontierpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thefrontierpost.com Daily Mail and Mail on Sunday newspapers.
A number of blood tests for Alzheimer's are being developed, and one is even now being sold to consumers, but none have been proven to be reliable, formally approved by regulators, or paid for by insurance companies.